Translate

Monday, January 22, 2018

thumbnail

BNTC Benitec Biopharma Limited gains 18% Jan 22, 2018

Developing gene therapies for hepatitis C based on RNA interference. http://www.priceseries.com/trade/BNTC-Benitec-Biopharma-Limited-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2018010320180122.html

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

TradeVisor Product Review

Review I II III IV

Blog Archive